Michael Recht/LinkedIn
Nov 26, 2025, 14:52
WFH Committee Member Highlight: Michael Recht on the Effectiveness of Octocog Alfa in Haemophilia A
World Federation of Hemophilia (WFH) shared on LinkedIn:
” Real-world data tell a powerful story.
In a recent study Octocog Alfa (BAY 81-8973) has shown effectiveness for people with hemophilia A, including under-represented groups, in the ATHN dataset.”
WFH has shared a committee member highlight from Michael Recht.
Read the full article here.
Article: Effectiveness of Octocog Alfa (BAY 81-8973) to Treat People With Haemophilia A Enrolled in the ATHNdataset, Including Under-Represented Subgroups
Authors: Martin Chandler, Thomas Moulton, Lena Charafi, Jessica Charlet, Michael Recht
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 9, 2026, 06:03Barbara Adams Krolak: ISTH Launches Global Women’s Health Hub
-
Jul 9, 2026, 05:49Abdul Mannan: A Low Platelet Count is not Always a Bone Marrow Problem
-
Jul 9, 2026, 05:41Julieta Rosales: Management of Tandem Strokes – To Stent or Not to Stent?
-
Jul 8, 2026, 21:30Matthew Gouveia: How VNS-REHAB Is Transforming the Future of Stroke Rehabilitation
-
Jul 8, 2026, 21:22What Hundreds of Stroke Stories Have Taught Diana Kerr About Recovery and Resilience – Stroke Foundation
-
Jul 8, 2026, 19:50Heghine Khachatryan: Why the EHC Fully Supports the Lancet Commission on Women’s Hematological Health
-
Jul 8, 2026, 19:40Autoregulation Failure in SVD and Cognitive Impairment – International Journal of Stroke
-
Jul 8, 2026, 19:30Ahmed Mostafa: Why Antibodies Cause Organ Rejection
-
Jul 8, 2026, 19:28Erika Bocanegra: Witnessing 25 Years of Progress in Bleeding Disorders Care